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Are you prepared to impact patient care? 
“Are you prepared to impact
patient care?” That was the chal-
lenge Dennis Helling, PharmD,
FCCP, FASHP, made to School of
Pharmacy students at the
Marguerite C. Holden Annual
Lecture held April 15. 
“We have known for 30 years
pharmacists can make a difference
in a variety of disease states,” said
Dr. Helling, executive director of
Pharmacy Operations and
Therapeutics for Kaiser Perma-
nente in Denver and an adjoint
professor in the University of
Colorado School of Pharmacy.
Preparing for a pharmacy career
was the subject of his lecture held
in Denison Auditorium.
Marguerite Holden, a CU graduate
and long-time benefactor of the
school, was present at the lecture
she supports. 
Dr. Helling explained that a
successful pharmacy career today
requires teamwork, good communi-
cations skills, building relationships
with nurses and physicians, and cul-
tivating a mentor relationship with
a faculty member or pharmacist. 
To show how a pharmacy career
has evolved over the past decade, he
gave examples of Kaiser's pharmacy
department, where pharmacists
operate in specialized roles provid-
ing enhanced patient healthcare,
education and counseling.
Dr. Helling's staff of 700 phar-
macists, clinical pharmacy special-
ists, technicians and administrative
support collaborates with physi-
cians to offer clinical pharmacy
expertise in such areas as primary
care, management of diabetes, coro-
nary artery disease, travel medicine,
infectious diseases, cardiology and
rheumatology. 
Pharmacists function as part of
a multidisciplinary team consulting
in drug therapies; developing pre-
scribing guidelines with physicians;
patient medication counseling and
education; and other patient-
focused services to optimize drug
therapy outcomes.
All clinical pharmacy specialists
at Kaiser have a PharmD degree
and a specialty faculty residency or
fellowship training, and within
their first three years of employ-
ment are required to receive board
certification of their specialty.
His advice to the students in the
audience was to get into a residency
program, which
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hire in primary care,
we save in drug costs
twice the amount of
their salary and bene-
fits,” he said. The
Pharmacy Automated
Refill Center (PARC),
by using robotic tech-
nology to produce
some 6,000 prescriptions a day,
frees up pharmacists so they have
more time for patient care activi-
ties. PARC utilizes bar codes, radio
frequency transmitters and drug
imaging to process 40 percent of
the total prescription volume.
Pharmacists perform clinical
screening and provide final checks
on prescriptions filled through the
PARC system. 
Two examples of areas overseen
by clinical pharmacy specialists in
Kaiser's centralized services are anti-
coagulation and cardiac risk where
results show a significant decrease
in complications and deaths.
Twenty pharmacists manage 6,500
active anticoagulation patients and
20 pharmacists manage 10,500 car-
diac patients in the Denver/-
Boulder area. 
Among the anticoagulation
patients there was a 39 percent
reduction in clotting complications
resulting in 25 lives saved each year,
while 193 deaths from secondary
heart attacks are avoided annually
in cardiac patients.
Transition of care is the focus of
the Clinical Pharmacy Call Center.
Whether it's a new patient to Kaiser
or a patient going home from the
hospital or a skilled nursing facility,
a team of clinical pharmacists han-
dle upwards of 1,200 patient calls a
day at the center. Pharmacists con-
tact patients to sort out medication
duplications, interacting drugs and
inappropriate over-the-counter sub-
stances before the patient sees a
Kaiser physician. Pharmacists and
physicians at the Call Center work
closely together in assisting their
patients.  
“Pharmacists organize all that
information and send it to the pri-
mary care physician for the first
visit,” he said, “so the physician can
concentrate on the patient and not
have to spend time sorting out med-
ications often time from physicians
and pharmacies outside of Kaiser.”
A pilot study revealed alarming
results for patients who were simply
discharged to go home from a
skilled nursing facility and then
became confused about their med-
ications. As part of the study, a
pharmacist called a third of the
patients discharged from skilled
nursing facilities within 24-48
hours of being home to review their
medication instructions. 
Comparing these to the other
patients, the study showed that one
phone call produced a 60 percent
reduction in hospitalizations and a
68 percent reduction in emergency
room visits within the next 30-60
days.
“If nobody is coordinating dis-
charged patients' medication, it's
really a train wreck waiting to hap-
pen,” he said. 
“You are not your father's phar-
macist,” said Dr. Helling. “You are
being trained at the highest level in
the history of our profession. Never
doubt that you can change the
pharmacy profession. You have an
obligation to do so.”
Dr. Helling finished his talk the
way he began, by asking the stu-
dents seated before him, “Are you
prepared to impact patient care?”
Dennis Helling, PharmD, FCCP, FASHP, chats with
pharmacy students after his lecture on April 15.
“You are being trained at the highest level in the
history of our profession. Never doubt that you
can change the pharmacy profession. You have
an obligation to do so.”  
— Dr. Dennis Helling
Marguerite C. Holden presents Dr. Dennis Helling with a
speaker's gift during the post-lecture reception. Mrs. Holden
is a graduate and long-time benefactor of the school.
SOP_Summer05.qxd  7/13/05  3:25 PM  Page 1





Dean, School of Pharmacy
Susan Saunders
Assistant to the Dean
School of Pharmacy
Catherine Bedell




Office of Public Relations
Kenna Bruner
Staff Writer









The CU School of Pharmacy is
one of 10 health professional
schools selected to participate in a
national collaborative to address
the review, promotion and tenure
processes applied to faculty who are
involved in community-based schol-
arship as part of their careers.
Funded by a three-year
$563,842 grant to Community-
Campus Partnerships for Health
from the U.S. Department of
Education's Fund for the
Improvement of Postsecondary
Education (FIPSE), the group of
schools will create templates to
show how faculty can be recognized
and promoted for community-
based scholarship.
“Community-based work is valu-
able and important, and universi-
ties should recognize faculty who
want to do work in this area rather
than simply categorizing it as serv-
ice,” said Catherine Jarvis,
PharmD, assistant dean for Student
Services and associate professor at
the School of Pharmacy. “This kind
of work helps the community, the
university and the students, so we
shouldn't be mired in a traditional
viewpoint that clinical and labora-
tory-based scholarship are the pri-
mary acceptable criteria for promo-
tion and tenure.” 
Historically in academia, in
order to be promoted and advance
in their career, members of the fac-
ulty are recognized for specific types
of research in traditional scientific
settings. That research has tradi-
tionally been focused in scientific
labs or in hospitals and clinics.
Healthcare faculty members who
have wanted to use their careers to
do research in the community have
found it more difficult to advance
their careers. 
“What happens is that this type
of good work in the community
doesn't progress unless faculty who
are doing it are recognized and pro-
moted for these activities,” said Dr.
Jarvis. “There's value in studying
things in a real community that
helps with the assessment of a drug
or other health care practices
beyond just studying them in con-
trolled laboratory settings. We need
to know things about the commu-
nity, about people's ethnicity and
culture and their beliefs about
health care.”
Each school in the collaborative
has formed a team of faculty and
administrators to lead the change
process. Members of the School of
Pharmacy's team include
Marguerite Childs, associate vice
chancellor of Academic Affairs for
the CU Health Sciences Center;
and pharmacy faculty members:
Sam Ellis, assistant professor;
David Hill, associate dean and asso-
ciate professor; Catherine Jarvis;
Christopher Turner, associate pro-
fessor; and Heather Ulrich, assis-
tant professor.
At the end of the three-year proj-
ect, the schools participating in the
collaborative will have significantly
impacted their promotion and
tenure systems to recognize and
reward community-engaged schol-
arship and stimulated similar
actions in professional schools
across the country.
Other schools participating in
the collaborative are Auburn
Less than a year after her
appointment to the Department of
Pharmaceutical Sciences, Assistant
Professor LaToya Jones, PhD, has
landed a one-year $75,000 grant to
collaborate with a CU-Boulder
researcher to go where few have
gone before.
Funded by the Butcher Awards in
Biotechnology, Dr. Jones and Dr.
Deborah Wuttke, associate profes-
sor in chemistry and biochemistry
at CU-Boulder will study vaccine
antigen/adjuvant interactions.
They will look at structural and
dynamical changes that occur in
proteins that have been adsorbed
onto adjuvants using nuclear mag-
netic resonance (NMR).
“We're stepping out there into
new territory,” said Dr. Jones. “I do
not know of a single publication on
this. Even with the research in my
lab in general, very few papers have
been published looking at the struc-
ture and stability of antigens from a
biophysical standpoint in the pres-
ence of the adjuvant.”
An adjuvant is a substance,
given with the antigen, that
enhances the response to the inject-
ed antigen.
A vaccine may work just fine
when it's in the presence of one of
the two adjuvants approved for use
in the U.S. (aluminum hydroxide
Adjuvant research exploring new territory
and aluminum
phosphate), but





















f o r m u l a t i o n s
before going into the more expen-
sive and long-term animal studies. 
“This grant allows us to come
together from different disciplines
and different campuses to try to
answer the same question,” said Dr.
Jones. “It will give us the opportu-
nity to see if our approach is worth
pursuing.”
By taking various mutants of a
protein adsorbed onto the adju-
vant, they will explore how alter-
ations of the conformation and sta-
bility of the protein affects the con-
sequences of its interactions with
the adjuvant. Dr. Jones will con-
duct the broader, biophysical char-
acterizations of proteins in suspen-
sion in her lab and then Dr.
Wuttke will use the high field
NMR spectrometers at the Boulder
campus to provide a detailed pic-
ture of how the structure is
changed in the presence of the
adjuvant. They will also seek to
delve into the differences in degra-
dation by proteases of antigen pre-
senting cells.
“The more we understand
what's going on in these systems,
the better chance we have of accel-
erating the development of more
efficacious vaccines, said Dr. Jones. 
SOP participates in national collaborative seeking to change academic culture
University Harrison School of
Pharmacy, Case Western University
School of Nursing, Indiana
University School of Dentistry,
Loma Linda University School of
Public Health, University of
Cincinnati College of Allied
Health Sciences, University of
Massachusetts Worcester School of
Nursing, University of Minnesota
Academic Health Center,
University of North Carolina-
Chapel Hill School of Dentistry
and Vanderbilt University School
of Medicine.
Assistant professor LaToya Jones, PhD, is collaborating with
a CU-Boulder lab to study vaccine antigen/adjuvant inter-
actions. 
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Carol Balmer, PharmD, director of the School of Pharmacy's
Office of Postgraduate Professional Education, was selected as the
2005 ACPE/AACP Scholar-In-Residence.
The Accreditation Council for Pharmacy Education (ACPE) and
American Association of Colleges of Pharmacy (AACP) Scholar-In-
Residence Program provides an opportunity for pharmacy educators
to work with ACPE staff and resources in addressing issues that
ACPE and continuing education (CE) providers (whether or not
based in a college or school of pharmacy) face in the development
and delivery of pharmacy continuing education. 
The goals of the program, which began in 2004, include provid-
ing an opportunity to increase scholarship of individual continuing
education providers and assist ACPE in addressing their goals.
During the residency, the participant researches and addresses issues
of importance to the AACP Continuing Professional Education
Section and ACPE. 
Dr. Balmer's project involves assessing the learning needs of CE
providers in developing skills related to performing scholarly activi-
ties and developing educational programming to meet those needs.
A study published in the 1998
Journal of the American Medical
Association reported that more than
one million hospital admissions
and 100,000 deaths each year are
due to severe adverse drug reactions
(ADR). This makes ADR the
fourth leading cause of death, after
cancer, stroke and heart disease.
Because so little is known about
these reactions, it is quite difficult
to predict which drugs will cause a
reaction and which patients will be
susceptible. With a five-year RO1
grant of more than $1.4 million,
Cynthia Ju, PhD, assistant profes-
sor of Pharmaceutical Sciences,
hopes to shed light on these life-
threatening reactions. 
“Due to our limited under-
standing of the underlying mecha-
nisms, it is impossible to predict
which drug candidates will cause
immune reactions until thousands
of patients start to use the drug dur-
ing clinical trials or after the drug is
released onto the market,” she said.
“The earlier we detect these reac-
tions, the better it is for patients
and the drug industry.”
It is estimated that 6-10 percent
of ADR cases are immune-mediat-
ed reactions, which include
halthotane-induced allergic hepati-
tis (one in 35,000 with a mortality
rate of 40-50 percent), pro-
cainamide-induced lupus (one in
six) and severe hypersensitivity syn-
drome induced by a number of
drugs, such as carbamazepine, aba-
cavir and nirverapine.  (Halthane is
no longer used in adults in Europe
and the U.S.)
Immune-Mediated Adverse
Drug Reaction (IADR) is due to the
formation of immunogenic drug-
protein adducts, however,
researchers are puzzled why most
people do not show clinical symp-
toms of IADR. Dr. Ju hopes the
five-year National Institute of
Health-funded study will reveal the
mechanisms of IADR and help





this kind of reaction is








that small. The hypoth-
esis is that chemically
reactive drugs, or more
often, reactive metabo-





It's like poison ivy.
When exposed to the
urushiol chemical in the sap of poi-
son ivy, an individual develops a
poison ivy-induced skin rash. This
occurs because the small molecular
weight chemical in poison ivy forms
a hapten-protein adduct. Haptens
are small molecular weight chemi-
cals that by themselves are not
immunogenic until they bind with
proteins. The hypothesis is that
drugs act like haptens.
Dr. Ju and her research team are
developing a mouse model of
halothane-induced hepatitis. The
reason IADR is not well under-
stood is because there is no animal
model. The rationale for choosing
halothane and mice for the study is
four-fold: halothane hepatitis is a
prototypic IADR; halothane is used
in most studies of IADR; mouse
immunological tools are available;
and various strains and transgenic
mice are available.
“Many research groups have pre-
viously tried to develop such a
model without success,” she said.
“We have so far been very pleased
with our results.”
Early data shows that the adap-
tive immune system is important.
They are investigating the mecha-
nism involved in immune-mediated
liver damage and have come up
with a strategy to develop a method
to screen the potential of drugs to
cause IADR. On average, it costs
$800 million to develop a drug. At
present, pharmacology and phar-
macokinetic/pharmacodynamic
issues are much better understood
and solutions can be found in most
cases. ADR, however, becomes the
most significant hindrance to drug
development. Pfizer has taken great
interest in Dr. Ju's initiative to
develop screening methods and
decided to fund this project.
Dr. Ju's lab is also investigating
the mechanisms of immunological
tolerance to drugs. One possible
explanation for why only a small
percentage of patients are more sus-
ceptible to developing IADR is that
most people develop immunologi-
cal tolerance to drug-modified pro-
tein antigens as a default mecha-
nism. Understanding what is
involved in drug tolerance will lead
researchers to identify risk factors. 
Previously, her lab found that
macrophages in the liver are essen-
tial in inducing tolerance to drug-
protein adducts. Their recent stud-
ies revealed that these cells not only
act as poor antigen-presenting cells
(APC) and fail to induce T cell reac-
tion, but the cells are also capable
of actively suppressing T cell activa-
tion that is induced by other potent
APCs. 
Her second NIH grant-funded
study focuses on drug-induced
severe liver injury, which is the
most common cause of withdrawal
of drugs from the market. Drug-
induced liver damage accounts for
25 percent of fulminate liver failure
in intensive care units, however,
very little is known about the mech-
anisms involved. Dr. Ju's approach
is to use a mouse model of aceta-
minophen-induced acute inflam-
matory liver injury. 
“We found that depletion of
macrophages from the liver leads to
induced tissue damage, suggesting
that these cells are protective,” she
said. “We hypothesize that the pro-
tective effect is through counteract-
ing inflammation and promoting
tissue repair. Our ultimate goal is to
uncover molecular regulators,
which act on these cells and leads
to protective effects.”
Carol Balmer selected as 
a Scholar-In-Residence
Graduate students Michael Holt and Hao Yin; Cynthia Ju, PhD; post doc
fellow, Qiang You; and professional research assistant Linling Cheng
Researcher Cynthia Ju explores mechanisms of adverse drug reactions
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Gone are the days when a search
for research data meant going to
the nearest medical library to peer
at microfiche. Some relevant stud-
ies would be found, but the cum-
bersome process made a compre-
hensive survey of all available data
too time-consuming to be practical. 
Evidence-based medicine repre-
sents not so much a paradigm shift,
but an advancement of the tools
used by a clinician, Daniel
Friedland, MD, told the standing-
room only crowd in Denison
Auditorium on April 22. Today's
technology dramatically changes
how research can be accessed and
shared. The internet makes it possi-
ble for pharmacists to find and use
research more thoroughly and effec-
tively than ever.
“In large part, the revolution of
evidence-based medicine coincides
with the development of the inter-
net,” said Dr. Friedland, president
and CEO of Friedland Consulting
and assistant clinical professor in
the Department of Medicine at the
University of California at San
Francisco. Dr. Friedland is author
of Evidence-Based Medicine: A
Framework for Clinical Practice.
Evidence-based practice is the
process of systematically locating,
appraising, and using research find-
ings as the basis for clinical deci-
sions. It emphasizes the use of
research and evidence to guide clin-
ical decision making.
Basing clinical healthcare on
research rather than tradition is not
a new concept, but it has become
more significant as pharmacists
have begun looking at patient care
procedures through the lens of evi-
dence-based practice.
“Knowing how to blend the rig-
orous research with clinical experi-
ence, expert opinion and under-
standing of pathophysiology of dis-
ease is what is known as clinical
expertise,” he said. “To transfer the
evidence requires four key skills,
which are to frame the right clinical
question; find the best available evi-
dence to answer the question; eval-
uate it to make sure it's valid; and
know how to apply it to patients.”
Finding the pertinent evidence
hinges on how effectively the ques-
tion is framed, according to Dr.
Friedland, who demonstrated how
to locate evidence-based informa-
tion online in such web sites as
MEDLINE and the Cochrane
Collection. 
There are four components to a
well-framed clinical question,
which are patient population; the
Finding answers through evidence-based medicine
“Knowing how to blend the rigorous research
with clinical experience, expert opinion and under-
standing of pathophysiology of disease is what is
known as clinical expertise.” 
— Daniel Friedland, MD
predictor; the comparison predic-
tor and the outcome. As an exam-
ple, Dr. Friedland posed the ques-
tion a pharmacist might ask when
looking for research evidence on a
new asthma drug: In patients with
persistent asthma (patient popula-
tion), is the new drug (predictor)
more effective than inhaled corti-
costeroids (comparison predictor)
with respect to lung function, symp-
toms and the asthma exacerbation
(outcome)?
“If you leave out any of these
components you can be led astray,”
he said. “You can end up getting
the right supporting evidence to
the wrong question.” 
Evidence-based medicine is the
application of the best available evi-
dence to patient care. Rigorous
research is crucial, but may not be
sufficient to fully guide clinical
practice. Clinicians must bridge
from research to the care of
patients with compassion, accord-
ing to Dr. Friedland.
“Compassion puts evidence-
based medicine into context,” he
said. “Medicine is not only about
framing clinical questions, finding,
evaluating and applying the evi-
dence, but it's also about keeping
an open heart so we can more fully
contribute to the quality of
patients' lives.”Daniel Friedland, MD, right, Dean’s Distinguished Seminar Series speaker for
2005, with SOP Dean Louis Diamond, PharmD.
The University of Colorado School of
Pharmacy was given a first place award in the
American Association of Colleges of Pharmacy
2004 Innovations in Teaching competition. 
The school's curriculum has six introductory
pharmacy practice experiential (IPPE) courses and
the award was given for the third, fourth and fifth
courses in which students demonstrate increasing
competency counseling patients in community
pharmacies on non-prescription medications and
complete hospital-based activities. 
The first, second and sixth IPPE courses were
given “honorable mention” awards in the same
competition in 2000, 2001 and 2003. The school's
director of Experiential Programs, Chris Turner,
PhD, said “The school has implemented a chal-
lenging IPPE program in which students are given
patient care responsibilities at the start of their first
year and increasing patient care responsibilities in
every subsequent year.”As far as he is aware, no
other pharmacy school in the United States has
had similar recognition of its IPPE program.
Dr. Turner also said “the students cannot per-








tion is a valida-




evaluations of the second through sixth courses
have been published in the on-line American
Journal of Pharmaceutical Education and the full-text





National awards for school's 
Experiential Programs
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Thomas Anchordoquy, PhD
Chair-elect, Nucleic Acids Focus Group, American Association of  
Pharmaceutical Scientists
Finance Committee, American Association of Pharmaceutical Scientists
Jacquelyn Bainbridge, PharmD
Chair, Clinical Neuropharmacy Special Interest Group, American 
Epilepsy Society
Chair, Programming and Nominations Committee and Research  
Committee, Central Nervous System Practice and Research Network,   
American College of Clinical Pharmacy 
Board of Directors Advocacy Committee, Epilepsy Foundation of  
America
Executive Committee, Epilepsy Foundation of Colorado
Marc Fariss, PhD
Chair-elect, 2004-2005, Toxicology Division, American Society of 
Pharmacology and Experimental Therapeutics
Douglas Fish, PharmD
President, Society of Infectious Diseases Pharmacists
Laura Hansen, PharmD
Chair-elect, American College of Clinical Pharmacy Women's Health  
Practice and Research Network
Brian Hemstreet, PharmD  
Chair-elect, 2005, Adult Medicine Practice and Research Network, 
American College of Clinical Pharmacy
Chair, 2005, Membership Committee, American College of Clinical 
Pharmacy
Sunny Linnebur, PharmD
Chair, Task Force on Pharmacy and the Elderly, American College of 
Clinical Pharmacy
Chair-elect, Ambulatory Care Practice and Research Network, American 
College of Clinical Pharmacy
School of Pharmacy faculty - active leaders nationally
Tonya Martin
Secretary, Drug Information Practice and Research Network, American 
College of Clinical Pharmacy
Cindy O'Bryant, PharmD
Chair-elect, 2004-2005, Hematology/Oncology Practice and Research 
Network, American College of Clinical Pharmacy 
Secretary/Treasurer, 2003-2004, Hematology/Oncology Practice and 
Research Network, American College of Clinical Pharmacy 
Joseph Saseen, PharmD
Chair, the American Society of Health-System Pharmacists Commission 
on Therapeutics
Kathleen Stringer, PharmD
Regent, American College of Clinical Pharmacy
Rho Chi President Jennifer Lacoe presided over the
initiation banquet held April 19 at Brittany Hill
Restaurant.  In Dean Diamond's presentation, “How Do
We Know What to Believe,” he discussed the controver-
sial issues surrounding the recent drug withdrawals from
the market.
The business portion of the banquet was highlighted
by the induction of 25 new Rho Chi members: P2 stu-
dents - Micheal Andrews, Daniel Bates, Tyler Byassee,
Diane Desugny, James Farrar, Sean Fitzpatrick, Kevin
Flynn, Dawn Hollingshead, Xiaojun Lu, Monica Manatt,
Matthew Marshall, Jessica Meier, Sarah Mercer, Jennifer
Meyer, Asad Omar, Stacy Shadburne, Kate Tran, James
Vinton and Shaun White; P3 students - Jennifer Cooper,
Courtney Frisch, Sara Murphy, Davy To, Thien Tran and
Kristen Villalta.  
A new executive council for 2005-06 was nominated
after the banquet: 
President - Sarah Mercer
Vice-president - Matthew Marshall
Secretary - Asad Omar
Treasurer - Jennifer Meyer
Historian - Kevin Flynn
Student council representative - Diane Desugny
Standing from left to right are: Jennifer Meyer, Kristen Villalta, Michael Andrews,
Sarah Mercer, Dawn Hollingshead, Matt Marshall, Shaun White, Daniel Bates, Diane
Desugny, Jim Farrar, Jessica Meier, Jennifer Cooper, Xiaojun Lu, Monica Manatt, Kate
Tran 
Front row kneeling are: Tyler Byassee, Kevin Flynn, James Vinton, Stacy Shadburne,
Davy To, Sara Murphy, Thien Tran, Sean Fitzpatrick, Asad Omar  Not Pictured:
Courtney Frisch
Congratulations to Rho Chi inductees & new executive council  
We managed a 100 percent return on the surveys. Results tell us:
64 percent will reside in Colorado 
22 percent will enter residency programs
62 percent had two or more employment offers
78 percent had accepted jobs in their preferred type of practice
32 percent will practice in rural and/or underserved areas
79 percent will practice in the community/retail field
25 percent will practice in hospitals
15 percent will practice in settings such as managed care,
public health service and home health
Average starting salary for full-time pharmacists who responded -
- $91,800
Exit survey responses reveal graduating
PharmD students' plans
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Distinguished Coloradan Awards
Kevin Tripp, RPh
Kevin Tripp is the executive vice
president of Drug Operations and
president of Drug Store Division
for Albertson's, Inc. As the senior
drug executive at Albertson's, Tripp
is responsible for all pharmacy and
drug store operations.
A native of Wyoming, Tripp
earned his pharmacy degree at The
University of Wyoming School of
Pharmacy in 1978. He began his
career at an Osco store in Casper,
Wyoming, as a pharmacist intern
and management trainee. He spent
nine years in store management as
an Osco general manager and unit
manager of a combination food
and drug store.
Tripp has since held a number
of positions in pharmacy opera-
tions, regional operations, man-
aged care, pharmacy marketing,
advertising and sales. In 1997, he
was named to lead the national
drug store team and was promoted
to his current position in January
2001. 
Tripp is co-chair for Albertson's
Diversity Leadership Council. He is
also an executive board member for
the National Association of Chain
Drug Stores, and serves on their
Leadership Council and Charitable
Foundation Committees.
He was instrumental in procur-
ing the Albertson's Scholarships as
well as the Coca-Cola grant for the
School of Pharmacy. These awards
have since played a significant role
in the success of the school's diver-
sity program.
Tripp works out of Albertson's
Store Support Center in Scottsdale,
Ariz. He lives in Scottsdale with his
wife and two daughters.
James R. Hertel, BPharm, MBA
Jim Hertel is the publisher of
the Arizona and Colorado Managed
Care Newsletters, publications of the
Denver-based HCCA. For more
than 20 years, he has provided the
health care industry in Arizona and
Colorado with key competitive
information and insights on the
changing market for health care
financing and delivery. His other
publications include the Directory of
Colorado Managed Care (1985-2003),
the Competitive Analysis of the Denver
Healthcare Marketplace (1984-2000)
and the Arizona Managed Care
Directory (1995-2004).
A former HMO executive and
development consultant, Hertel
spent nearly a decade developing
HMO and PPO plans in Colorado,
California, Michigan, Ohio and
Wisconsin. He helped develop
Colorado's first pharmacy IPA, viz.
Denver Area Pharmacy Providers.
After graduation from the
University of Colorado, he worked
as a pharmacist for the Walgreen
Company.
Hertel is a frequent public
speaker on health care financing
issues. His annual State-of-the-State
programs in Arizona and Colorado
are popular and well attended by
healthcare industry leaders.
He is the chairman of the Board
of Trustees for the Platte Valley
Medical Center in Brighton, past-
chairman of the Western Regional
(Hospital) Trustees Symposium and
a member of the Board of Trustees
for the A.J. Kauvar, MD,
Foundation.
Hertel has been an active
member of the school's
Development Council, con-




Council programs. In addi-
tion, he has made signifi-
cant contributions to discus-
sions by alumni, faculty,
staff and donors in develop-
ing the vision for the
Fitzsimons campus. Hertel
has been an articulate and
effective advocate and an
asset to the school.
Teaching Awards
During the School of Pharmacy's Awards
Convocation and commencement activities in May,
several faculty received awards for their outstanding
contributions to education, research and community
health care.
David C. Thompson
2005 Chancellor's Teaching Recognition Award
And P1 Students' Teacher of the Year
David C. Thompson, PhD, came to the School of
Pharmacy as a research associate in 1987. He is now an
associate professor of pharmaceutical sciences. 
Dr. Thompson also received the Chancellor's
Teaching Award in 2000 and 2002,
and the President's Excellence in
Teaching Award in 1996 and 1997. 
A member of several profession-
al organizations, Dr. Thompson
has served as a grant reviewer for
several organizations, including the
National Institutes of Health. He is
also a journal referee for nine pro-
fessional publications, including
Life Sciences, Peptides, American
Journal of Respiratory and Cellular
Molecular Biology and Journal of
Clinical Investigation.
He is the author or co-author of
four book chapters and dozens of
publications and abstracts. His
research interests include pul-
monary delivery drugs and mecha-
nisms involved in lung cancer
development.
Dr. Thompson received both his
bachelor's and doctorate degrees
from the University of Melbourne.
Joseph J. Saseen
2005 President's Excellence in Teaching Award
And P2 Students' Teacher of the Year
Joseph J. Saseen, PharmD, FCCP, BCPS, joined the
pharmacy faculty in 1996 as an assistant professor in
the Department of Pharmacy Practice. He is now an
associate professor of clinical pharmacy and has a joint
appointment with the Department of Family
Medicine. He is a Board Certified Pharmacotherapy
Specialist with Added Qualifications in Cardiology,
and is a Fellow of the American College of Clinical
Pharmacy. 
He received the President's Award in 1998 and 2002,
and the Chancellor's Teaching Recognition Award in 2003.
Dr. Saseen is a member of the American College of
Clinical Pharmacy Board of Regents, and is the Chair
of the American Society of Health-Systems Pharmacists
Commission on Therapeutics.
He received both his bachelor's and doctor of phar-
macy degrees from State University of New
York at Buffalo.
Laura Hansen, PharmD, BCPS
2005 P3 Students' Teacher of the Year
Laura Hansen is an assistant professor in
the Department of Clinical Pharmacy in
the School of Pharmacy and the
Department of Family Medicine in the
School of Medicine. She joined the faculty
in 2000 after several years teaching at
Shenandoah University School of
Pharmacy.
She earned her BS in pharmacy from the
University of Iowa and her PharmD from
the University of Colorado in 1997. She
then completed a primary care specialty res-
idency with the University of Colorado and
Kaiser Permanante.
A member of several school committees,
Dr. Hansen belongs to six professional asso-
ciations, is a journal referee for seven pro-
fessional journals and is the author or co-author of
more than a dozen articles and abstracts.
The courses she teaches at CU include Family
Medicine Specialty Clerkship, Integrated Organ
Systems, Pharmacist Based Immunization,
Comprehensive Patient Care, Professional Skills
Development and Experiential Practice.
David C. Thompson, PhD, left,
received the 2005 Chancellor's
Teaching Recognition Award
and P1 Students' Teacher of the
Year. Joseph J. Saseen, PharmD,
FCCP, BCPS, received the
President's Excellence in
Teaching Award and P2
Students' Teacher of the Year.
Kevin Tripp, RPh, left, and James Hertel, B
Pharm, MBA.
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PharmD Students
Kappa Epsilon Outstanding Leader Awards
Debrah Howell
Kelley Miller     
Phi Delta Chi Pharmacy Spirit Award 
Matthew Marshall        
Phi Lambda Sigma Leadership Award 
Abraham Wick          
Rho Chi Outstanding Student Award
Jennifer LaCoe           
Roche Pharmacy Communications Award
Richard Blaskovich        
School of Pharmacy Clinical Practice Award
Sunset Andersen 
GlaxoSmithKline Patient Care Award
Jennifer Carnell         
Mylan Pharmaceuticals Excellence in Pharmacy Award
Jeremiah Miller
APHA/ASP Mortar and Pestle Professionalism Award
Heather Carwin





Dawn Hollingshead, Kerri Martinez and Jennifer Meyer
TEVA Outstanding Student Award 
Aimee Thompson
School of Pharmacy Outstanding Scholastic Achievement Award
Parisa Shahmohammadi
School of Pharmacy Scholastic Achievement Awards
Jessica Meier and James Vinton
Department of Pharmaceutical Sciences Awards
Michael Long, Edward Paul O'Donnell and 
Parisa Shahmohammadi
School of Pharmacy Professional Achievement Awards
P1: Patrina McCauley
P2: Sarah Mercer 
P3: Laura Van Horn
P4: Nerissa Moore
The Lilly Achievement Award
Roy Brunson
Student Council Presidential Award
Nellianna Shaffer
The Dean's Distinguished Student Award
Heather Lindell
The Lefler Book Award
Heather Hess
Holden Community Service Award
Kappa Epsilon
L.L. Lubin Award   
Asian American Pharmacy Students Association
PhD Candidates
David Carbone 
First place - Carl Smith Graduate Student Award for Meritorious 
Research; Mechanisms Specialty Section of the Society of 
Toxicology 
Tia Estey
Competitive Travel Award, 2005 Association for Research in 
Vision and Ophthalmology (ARVO) 
Student groups recognized 
for community service
Asian American Pharmacy Students Association
Members of the Asian American Pharmacy Students Association
(AAPSA) received the L.L. Lubin Community Service Award.  
This award was created in memory of Lubin Lutz, a graduate of
Capital Pharmacy School in the 1940's.  His family, using funds con-
tributed in lieu of flowers at the time of his death in 2002, wanted
to provide an award to further diversity through support of students.
It was suggested that student service projects advancing health care
for under-represented groups would give the dollars the greatest
impact in the school and community.  
Over its initial two years of existence, the AAPSA's members have
participated in activities to bring health screening information to the
community, including the 9News Health Fair, an osteoporosis
screening held at a Buddhist temple and providing hypertension and
diabetes prevention information to the Vietnamese community.  
In addition, the student members have worked to improve cul-
tural awareness on campus in entertaining ways with food, music and
the celebration of the Lunar New Year, also known as the Chinese
New Year.  The funds from the L.L. Lubin Community Service Award
will aid AAPSA in continuing these activities and expanding to pro-
vide brown bag counseling sessions.
Kappa Epsilon
The Kappa Epsilon (KE) chapter of the School of Pharmacy was
selected for the second year as the recipient of the Holden Community
Service Award.  In keeping with the national organization's focus on
breast cancer awareness, chapter members participated in the Komen
Race for the Cure.  
On a local scale, members put together baskets of personal items
for newly diagnosed breast cancer patients treated at the University
of Colorado Cancer Center.  KE members continued their involve-
ment with the Grant Street Reach, serving hundreds of meals to
homeless and poverty-stricken people in the Denver area, and pur-
chasing clothes and gifts for children and teens of homeless families. 
Two new projects included the Brandon's House Adopt-A-Room
program and a poison prevention program for grade-schoolers.  For
the Adopt-A-Room program, chapter members chose a design
scheme, then purchased decorating materials and painted and deco-
rated one room in a home for battered women and children.  The
poison prevention project had KE members bringing second grade
students from a neighborhood elementary school to the campus.
They taught the children about poison prevention and let them do
some role playing as pharmacists, compounding diaper rash cream
and counseling each other in the use of pretend medications.
The funds from the Holden Community Service Award will enable
KE to continue these projects and expand their outreach.
Awards and Recognition for exceptional students
Natalie Lassen
Lassen N, Estey T, Tanguay R, Pappa A, Reimers M, Vasiliou 
V., Molecular Cloning, Baculovirus Expression & Tissue 
Distribution of Zebrafish ALDH2.  
Drug Metabolism and Disposition 
Brante Sampey
Webb-Waring Institute's Graduate Student Research Award 
(2005).
UCHSC Graduate Student Research Forum
Brante Sampey 
Honorable Mention -Carl Smith Graduate Student Award for 
Meritorious Research;  
Mechanisms Specialty Section of the Society of Toxicology
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Rho Chi, Phi Lambda Sigma
Anthony Robert Blackmore




Rho Chi, Phi Lambda Sigma
Heather Michele Carwin









Rho Chi, Phi Lambda Sigma
Tracey Gean Davis








































Rho Chi, Phi Lambda Sigma
Daniel Gustavo Moreno




























Rho Chi, Phi Lambda Sigma
Patricia Padgett Saunders
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James R. Stephens, III, was selected to receive the School of
Pharmacy's Leadership Award as the outgoing president of the
Colorado Pharmacists' Society.  His educational history is a strong
statement of his dedication to health care beginning with a BS
degree in nursing from the University of Wyoming in 1983.  
Stephens followed this with a BS in Pharmacy in 1987, also
from Wyoming, and an MBA in Health Care Management in
1997 from the University of Dallas at Irving, Texas.  He antici-
pates graduating from the University of Colorado School of
Pharmacy's Non-Traditional Doctor of Pharmacy degree program
in May 2006.  
Since 1999, Stephens has been the director of Pharmacy
Services at the Platte Valley Medical Center in Brighton, where he
started a pharmaceutical care model of practice. His responsibili-
ties include leadership and management of pharmacy services.  
He has served as the president of both the Colorado
Pharmacists' Society and the Wyoming Society of Health System
Pharmacists and held other officer and board positions in these
organizations.
This is the first in a series of articles about preceptors who were recog-
nized at the 2005 commencement for their teaching and professional skills. 
Jacquelyn Bainbridge: 2005 Preceptor of the Year
Associate Professor Jacquelyn “Jacci” Bainbridge, PharmD, was
named 2005 Preceptor of the Year by School of Pharmacy students.
She also received the award in 2003.
Dr. Bainbridge holds dual appointments in the SOP's
Department of Clinical Pharmacy and the School of Medicine's
Department of Neurology.
She received her BS in pharmacy from Ohio Northern
University and graduated in 1995 from the first PharmD class at
the University of Colorado. After completing a residency in neu-
rology at CU, she accepted a position with the SOP faculty in 1996.
After graduating, she put together her own specialty residency
in neurological pharmacy for her advanced training and she fund-
ed it with research dollars she generated. After the residency Dr.
Bainbridge then created her faculty position, since there was not a
faculty member who specialized in neurology at the time. 
She considers the study of neurological pharmacy a pharma-
ceutical gold mine because it is rich in opportunities. Her neuro-
logical specialties include epilepsy, multiple sclerosis, headache and
neuroprotection. The drugs in neurological pharmacy are among
the leading groups of drugs that cause adverse events, such as a hos-
pital admission.
“This is a problematic group of drugs, because these drugs interact with
so many other medications and food,” she said. “You have to think about
how the drug works, the mechanism of action, and relate that back to its
chemical structure in pharmacology and then use that as a basis for mak-
ing recommendations about dosing.”
Ralph Altiere, PhD, professor
and associate dean, received the
2005 Dean's Award for Distinguished
Leadership in the School of Nursing
(SON). This is a special award that
recognizes faculty who have provid-
ed exceptionally meritorious serv-
ice to the school.
Dr. Altiere received this award,
according to Patricia Moritz, PhD,
RN, FAAN, dean of the School of
Nursing, due to his major contribu-
tions to the SON through his out-
standing and continuous generous
Professor receives nursing
leadership award
service to the school's Dean's
Review Committee.
“I thank you for your participa-
tion, professionalism, commitment
of effort and dedicated service to
this committee,” wrote Dean
Moritz. 
“Your input and efforts in the
academic reviews were extremely
valuable and beneficial to us. Your
willingness to participate for many
years in this important academic
process is very much  appreciated.”
Preceptors: Preparing students to become colleagues
She began precepting for pharmacy students in 1998 while working in
the Critical Care Unit at the University of Colorado Hospital. 
The key to successful precepting, according to Dr. Bainbridge, is instill-
ing confidence in students by allowing them to be independent, and yet
always being accessible to them.
“I try to build the type of pharmacist I would want to work next to in
the trenches because, when they finally walk out that door, they're a col-
league,” she said. “I adapt my teaching style to the individual needs of the
students. With every new student, I'm faced with a new challenge and I
like that.”
Dr. Bainbridge has been a principal investigator or co-investigator on
clinical trials for epilepsy, multiple sclerosis and Parkinson's disease. In
addition to serving as a preceptor for P4 students doing their clinical rota-
tions, she established a specialty residency in neurology for post-graduates.
It is currently on hold due to a lack of funding, but she hopes it will be
restored soon.
“We need more practitioners in neurology across the country,” said Dr.
Bainbridge. “Only a handful of people are doing what I do. There's a huge
need for more of us.”
From left, Jacquelyn Bainbridge, PharmD, Institutional Preceptor of the
Year; Charles Sintek, MS, RPh, BSPS,  Ambulatory Preceptor of the Year,
and  Shari Bohn, RPh, Roche Preceptor of the Year.
SOP Leadership Award
What was the entire administrative staff of the School of
Pharmacy doing in a pool room in the middle of a workday at
Governor's Park in Denver?  The occasion was the Staff
Recognition Luncheon.  If there were doubts about the location,
they were erased when the delicious meals were served.  The dean
and other officers of the school honored the 23 staff members for
their years of service.  Six of the 23 employees have been with the
school more than 10 years. The staff's combined years of service
to the school total 177.  The lunch and a later delivery of snack
baskets were greatly appreciated by the staff.
Staff recognized for
years of service
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This year's awardees were: 
Best Science Podium 
CAPSID SCAFFOLD PROCESSING
IN HERPES SIMPLEX VIRUS
Raeanna Nerpel and Carlos Enrique
Catalano
University of Colorado at Denver
and Health Sciences Center, School of
Pharmacy, Denver, CO
Best Science Posters
THE INFLUENCE OF LIPID EXCIP-
IENT, CAPRYOL PGMC AND GELU-
CIRE 44/14 ON P-GLYCOPROTEIN
ACTIVITY
Andrea Thamboo, Kristina Sachs-
Barrable, Stephen Lee and Kishor M.
Wasan
Faculty of Pharmaceutical Sciences,
Vancouver, British Columbia
INVOLVEMENT   OF   RECEPTORS
IN   THE   ACTIONS OF  3,4-METHYL-
ENEDIOXYMETHAMPHETAMINE
(MDMA)
Matt Brammer, Debbie L. Gilmore,
Jamaluddin Shaikh, Buddy Pouw and
Rae R. Matsumoto
University of Oklahoma Health
Sciences Center, College of Pharmacy, 
Oklahoma City, OK and University 
of Mississippi, School of 
Pharmacy, University, MS
Commitment to research conference showcases students' work
Best Clinical Podium
MYCOPHENOLIC ACID EXPOSURE
AND GRAFT VS HOST DISEASE IN
HEMATOPOIETIC CELL TRANSPLAN-
TATION
Janel Long, Pamala Jacobson, John
Rogosheske, Juliet Barker, Kathleen
Green, Juki Ng, Daniel Weisdorf,  Ye Tan,
Rory Remmel, Ronald Sawchuk and 
Philip McGlave.
Experimental and Clinical Pharmacology, 




REVIEW OF ALBERTA HEALTH AND




Colleen Shouldice, Jody Kluchky and
Harold Lopatka
Alberta Drug Ultilization Program,
Edmonton, Alberta, Canada
The Eighth Annual Pharmacy Student Research Conference was
opened June 3 by University of Colorado School of Pharmacy Associate
Dean Dr. Ralph Altiere, who founded the conference in 1998 with fund-
ing from The Merck Company Foundation.  The conference offers a
unique venue for pharmacy students to present results of their research
efforts and to interact professionally and socially with student and faculty
colleagues from many other pharmacy schools.
The primary goals of the conference are to promote research among
pharmacy students and foster participation in advanced research studies in
areas of pharmaceutical science, pharmacy practice, administration, social
sciences, outcomes research, or pharmacy education. 
The keynote address was delivered Friday evening by Robert MacLaren,
BS, PharmD, an assistant professor at the University of Colorado School
of Pharmacy.  His talk, titled Clinical Research: A Potpourri of Opportunities,
provided students with examples of the opportunities that await them in
clinical research by expanding on his current research endeavors.  Dr.
MacLaren's current research includes evaluation methods to improve the
nutritional care of critically-ill patients and their access to appropriate use
of specific therapeutic agents and a clinical trial to evaluate the immuno-
protective effects of the amino acid, glutamine, in liver transplant patients.  
On the second day of the conference, 12 podium talks and 36 posters
were presented at the School of Pharmacy by students representing 16 U.S.
and two Canadian pharmacy schools in the western region.  Twenty-three
faculty sponsors and other guests from 16 of the represented schools also
attended.  Presentations were reviewed by two panels of judges comprised
of faculty members from the represented schools and awards were given for
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Graduates of the School of Pharmacy's Nontraditional PharmD Program prepare to
receive their diplomas.
For Renee Jahnke, PharmD, the
knowledge she gained from the
Nontraditional PharmD (NTPD)
program not only prepared her for
a satisfying career, it helped her
family better understand what was
ahead when her unborn child need-
ed a new heart.
Dr. Jahnke became pregnant
after completing the NTPD pro-
gram in August 2003. In January
2004, she and her husband learned
their unborn son had a rare con-
genital heart defect called
Hypoplastic Left Heart Syndrome
in which the left ventricle of the
heart didn't develop. The treatment
choice was either a heart transplant
or a series of three open heart sur-
geries which would start when their
baby was one week old and end
when he was about five.
After many appointments with





t r a n s p l a n t
team, the
couple decid-
ed a heart transplant would be their
son's best hope for a normal life. At
36 weeks of gestation, Baby Boy
Jahnke was listed on the heart
transplant list. He was first on the
list. Had a donor heart become
available, Renee would have had a
caesarian section and the trans-
plant would have been performed
immediately.
Noah was born April 14, 2004,
at 8 lbs. 14 oz., and was as pink and
healthy-looking as any newborn,
according to Dr. Jahnke. After she
gave Noah a quick kiss, the NICU
nurses swept him away and he was
put on IV prostaglandin to keep his
patent ductus arteriosus (PDA)
open and nitrous oxide to regulate





s t a y e d
o p e n ,
Noah could circulate blood just as
he did in the womb. He was trans-
ferred to The Children's Hospital
at three days old and Dr. Jahnke
and her husband Mark were
allowed to hold him for the first
time.
A tiny stent was inserted in
Noah to keep the PDA open. At
three weeks old, Noah was taken
home to wait for a healthy heart.
The only medication he required
was half a baby aspirin every day,
which Renee crushed and diluted
with water. Twice a week Noah
was taken to the transplant clinic
at Children's to be monitored.
When Noah was nine weeks
old, they got the call they'd been
waiting for - a donor heart was
available.
“We were so excited and yet so
sad,” she said. “Another family
(had) just gone through some
tragedy and lost their baby.”
They went straight to the
CICU at Children's. Noah was
given his first dose of the anti-
rejection drugs, cyclosporine and
mycophenolate. A transplant couri-
er stopped by the bedside with a lit-
tle red cooler on his way to retrieve
the donor heart. A jet waited for
him at the airport. At that time, the
couple wasn't allowed to know any-
thing about the donor.
Just after midnight on June 18,
2004, Noah was taken to the oper-
ating room where the transplant
team of 10 health care professionals
opened up his chest and got him
ready for the transplant. At 7 a.m.
the next morning, a nurse came out
to tell the couple that Noah's new
heart was beating vigorously on its
own and the team was closing up
his chest.
“The first echocardiogram
Noah had after the transplant was
so exciting for us,” remembered Dr.
Jahnke. “After all those long
months of seeing only three cham-
bers functioning, we could now see
all four chambers!”
Six days after the transplant
Knowledge from NTPD program helped '03 graduate cope with ordeal
Noah went home. He was initially
on six medications: cyclosporine,
mycophenolate, nystatin, furose-
mide, enalapril and ganci-clovir.
Within a month, Noah was
taken off all the medications except
the anti-rejection medications.
After a month, transplant patients
are taken off mycophenolate and
switched to azathioprine suspen-
sion (compounded), as long as
there have been no complications
or signs of rejection, according to
Dr. Jahnke. 
There are special medication
issues in giving chronic medica-
tions to babies. It's important that
the anti-rejection medications be
given at the same time every day to
keep levels consistent. Babies are
not allowed to have pacifiers or bot-
tles for 10 minutes after receiving
the cyclosporine, because the med-
ication adheres to the rubber and is
not absorbed into the body. And if
the babies spit up within 15 min-
utes of taking the cyclosporine, the
full dose must be given again.
Slowly, Noah graduated to once
weekly clinic visits, then every other
week, and now once a month. He
will have a heart catheterization
every year and a biopsy will be
taken to ensure that there are no
signs of rejection. His first heart
catheterization is scheduled in July.
If everything is normal, the azathio-
prine suspension will be discontin-
ued and Noah will only be on the
cyclosporine, which he'll take for
the rest of his life. 
Noah has developed like any
other baby and is expected to live a
normal healthy life. He started
crawling at six months and took his
first steps just before he turned one
year old. He can say “mama” and
“dada” and jabbers all sorts of
other unintelligible words. 
Renee and Mark were given an
opportunity to write to the donor
family who lives in Salt Lake City
and the two families are now in reg-
ular contact with each other. The
donor family's second daughter,
Rielly Nicole, died of SIDS when
she was five months old.
“They tell us knowing Noah and
knowing how well he is doing has
helped them deal with their loss
and begin living again,” said Dr.
Jahnke. “What a miracle and a
blessing our son is!”
A pharmacy supervisor for
Kaiser at Hidden Lake Clinic in
Denver, Dr. Jahnke continues to
work with the NTPD program as a
student advisor in the new Credit
by Challenge Advisor program.
Noah Jahnke at one year.
Here comes the future ...
When Noah was nine weeks old,
they got the call they'd been waiting
for - a donor heart was available.
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Suegie Park is one of those fortunate indi-
viduals who was able to turn the passion of
her life into her life's work.
Park is a summer graduate of the School of
Pharmacy's Nontraditional PharmD (NTPD)
program, which is a Doctor of Pharmacy
degree program offering courses via the inter-
net. In Denver, half a world away from her
native country of Korea, she is using her phar-
macy knowledge to help in community serv-
ice and public health education.
“When I make a benefit in another's per-
son's life, it makes me happy,” she said. “I
have a passion to take care of other people.”
In 1975 Park and her husband immigrated
to the United States and both of them joined
the U.S. Army in order to continue their edu-
cation. The couple was stationed at Ft. Riley
in Kansas where she worked in finance and
administration. After her honorable dis-
charge from the service, Park and her hus-
band and their two small daughters moved to
Denver and she enrolled in the School of
Pharmacy at CU-Boulder.
During her first year of school, Park com-
muted by bus to Boulder, but the long hours
spent on the road began to take its toll on her.
In her second year at CU, Park stayed in a
dorm Monday through Friday, going home to
her family on weekends. Even her time at
home during the weekend became limited
while she worked at the Presbyterian Hospital
in an internship. After earning her pharmacy
degree, she worked as a clinical pharmacist in
Denver. Park's pharmacy career was sidelined
in 1994 because of severe, chronic pain from
nerve damage caused by pelvic surgery. When
pain medication couldn't relieve her suffer-
ing, she turned to alternative therapies such
as acupuncture and meditation, which offers
her some degree of relief.
“I couldn't go back to work. I couldn't do
anything, but I wouldn't give up,” she said.
Not one to let a physical challenge keep
her down, Park became an active volunteer
and advocate for health care in Denver's
Asian community. 
By combining her passion for pharmacy
and her desire to be of valuable service to
non-English speaking Asians, Park is helping
address some of the health care issues in her
own community.
In 1995, she began volunteering at the
annual 9NEWS Health Fair. A Korean
woman who had a screening blood test at one
of the fairs looked for Park the following year
to thank her. Park had translated into Korean
the test results showing abnormal thyroid lev-
els. Because of early detection, the woman's
thyroid cancer was successfully treated.
“When I hear stories like that, I know I
can't quit, even when I get so tired,” said Park.
“My husband and daughters are very support-
ive; that's how I can continue.” 
Due to Park's efforts, free screenings for
hepatitis B are conducted in the Asian com-
munity. Out of the 190 Korean and
Vietnamese people who participated in the
first screening, more than 70 percent tested
positive for hepatitis B. From the screening
project she began collaborating with a
researcher from the School of Nursing on a
grant-funded hepatitis B study. She is also
working with another researcher on a prostate
cancer prevention trial to increase the num-
ber of Asian-Americans who parti-cipate in
and complete the trial.
Because of the SOP's NTPD online cours-
es and individualized format, Park was able to
take classes that fit her schedule. She credits
the encouragement of SOP faculty members
Carol Balmer, PharmD, and Chris Turner,
PhD, for her successful completion of the pro-
gram and looks forward to continuing her
pharmacy work in the Asian community. 
“I highly recommend this program to
working pharmacists to gain more knowledge
and make a difference in their career,” she
said. 
NTPD online courses a good fit for a busy student
Annibel Gardner Scholarship Jennifer Spears
Eryn Roth
Anthony J. Lembach Scholarship Stacy Shadburne
Burroughs Wellcome Endowment Scholarship Katey Girard
Chancellor's Diversity Scholarships
Oluseun Abolaji Michele Garcia Paul O'Donnell
Daniel Bates Nancy Hoang Tomas Sandoval
Reannon Castilleja Debrah Howell Latrena Solomon
Elena Chemanaeva Jasmine Le Jessica Trujillo
Jennifer Cooper Patrina McCauley Christina Yu
Colorado Pharmacists Society Scholarship Wendy Johnson
Sommer Zarbock
Colorado Pharmacy Foundation Scholarships Wendy Johnson
awarded in honor of Lillian Bird Sommer Zarbock
Erwin-Vincent Scholarship Duy Tran
Sara Kwon Memorial Scholarship Kerri Martinez





James L. McDowell Memorial Scholarship Tasheba West
University of Colorado School of Pharmacy
Scholarships, May 6, 2005
McKesson Scholarship Amy Sion
National Association of Chain Michelle Pulido
Drug Stores Scholarship
Southern Colorado Society of Health-System Evelyn Phan
Pharmacists Scholarships




Kaiser Permanente Kent M. Nelson Scholarships
Richard Blaskovich Stacey Shadburne
Dawn Hollingshead James Vinton
Kerry Martinez Sommer Zarbock
Raeanna Nerpel
King Soopers Scholarships
Michael Appel Sarah Mercer Christopher Ryan
Jessica Engelbert Binh Nguyen Angela Stevens
Jessica Hoang Jenny Nguyen Hilda Taban
Rory Lambert Leann Nguyen Minh-Thuy Nguyen
Hung Le Xuan Nguyen Duy Tran
Stephanie Jones Rashmiben Patel Trang Van
Francis Macalalag Jon Peterson Janell Watkins
Shannon Matsko Tuyet-Hong Pham Jill White
Teresa McMahan-Shulkin Memorial Scholarship Heather Hess
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On Saturday, May 21, 10 class members and their spouses got together
for dinner at Brooklyn's Restaurant across from the Pepsi Center in
Denver to celebrate their 20-year School of Pharmacy reunion.
People came from as far away as Michigan and Washington.
Friendships were renewed, pharmacy-work war stories were exchanged,
and a lot of reminiscing went on.  
The food was fine and the company divine. They're hoping to have an
even greater turn out at the next get-together.  
If you would like to be on the Class of 1985 group email and receive a
class directory, please contact kathimillner@comcast.net 
Dean Diamond presents lecture
at University of Kentucky
SOP Dean Louis Diamond is flanked by University of Kentucky Dean
Kenneth B. Roberts and Dean Emeritus Joseph V. Swintosky.
Dean Louis Diamond traveled to the University of Kentucky in
mid-April to deliver the Swintosky Distinguished Lecture.  Annually,
an outstanding national or international scientist/educator is invited
to the UK College of Pharmacy to present the lecture and to interact
with students, faculty and pharmacists.  Dr. Diamond's distinguished
career and outstanding reputation in pharmaceutical sciences and
pharmacy education were cited as reasons for his being selected to be
the 2005 Swintosky lecturer.  
The lecture series is named in honor of Dr. Joseph V. Swintosky
who served as dean of the UK College of Pharmacy from 1966 until
1986. Under Dean Swintosky's leadership, the Kentucky college
emerged as a world-class institution.  
“Flip Flopping Along the Road to Rational Therapeutics” was the
title of Dean Diamond's presentation.  It covered the history of radi-
cal and hard won advances in scientific and medical knowledge
regarding disease causation and treatment.  Dean Diamond used sev-
eral historical examples to demonstrate how reliance on tradition or
authority rather than objective scientific evidence can retard medical
and therapeutic progress, while at the same time, take a devastating
toll on human life and suffering.  
After the lecture, Dean Diamond was presented with a plaque and
a $1,000 honorarium which he donated to the UK College of
Pharmacy's student fund.      
Before assuming his present position, Dean Diamond was on the
faculty of the UK College of Pharmacy from 1967 until 1986.
Class of 1985 
celebrates 
20-year reunion
Front row: Ray Ristau, Julia Rawlings, Wendy Anderson, Gayla Goss, Kathi




Dean M. Chetkovich, '63, wrote to tell us he's officially retired
for the second time.  His first retirement, after 32 years with Kroger,
came in November 2001. The past four years he's been in inde-
pendent retail pharmacy in south Texas. His career also included
six years of practice before his tenure with Kroger. Chetkovich start-
ed at The Apothecary at the University of Colorado at Boulder; fol-
lowed by U.S. Public Health Service assignments at Shiprock and
Crownpoint, New Mexico, and Keams Canyon, Ariz.; and finishing
with several community pharmacy stints in Denver and then West
Virginia.  
His experiences ranged from hospital pharmacy, retail, manage-
ment, IV admixtures, compounding and Hospice pharmacy service.
Chetkovich settled in Texas in 1969 and is retired in Seguin, Texas.
James M. Tyler, Jr., '55, and his wife Helen, who put him
through school, sent their regards to classmates in anticipation of a
50th reunion gathering in May.  They report good health with a few
memory problems and confess that ranch life can get the better of
them on occasion.  They'd love to hear from school friends and
catch up on past years.  Feel free to contact them at P.O. Box 1173,
Meeker, CO 81641-1173 or 970-878-4822 or jimtioway@amigo.net.
In Memoriam
SOP News received notice that Daniel S. Heffron, III, '77, passed away
on December 20, 2004, in Littleton, Colorado.
Robert Warden, '50, passed away on May 21, 2005. He was a pharma-
cist in La Junta and Fort Collins before moving to Granby in 1953.  In
addition to co-owning Granby Drug, Robert Warden was mayor of Granby
and served on the town council and several boards.  Shirley and Robert
had recently moved to Denver where she remains.
Errata: 
We extend our apology to Julia Rawlings for omitting her name from
the 2004 donor Honor Roll.
We extend our apology to John A. Biles, '44, for not including his
name in the list of Lifetime Benefactors of the School of Pharmacy begin-
ning in 2003.
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Agarwal Research Triangle Institute, NIH subcontract
Pure Flavonolignans form Silybum Marianum in Prostate Cancer
$674,236 8/1/04 — 3/31/09
Agarwal NIH/NCI
Colon Cancer Chemoprevention by Flavonoid Silibinin
$1,510,090 3/1/05 — 2/28/10
Agarwal NIH NCI
Angioprevention of Lung Tumorigenesis by Silibinin
$1,505,770 4/1/06 — 3/31/10
Anderson American Association of Colleges of Pharmacy
Phoosphorylation of Nucleoside Analog Antiroviral Drugs in Purified CD4
Lymphocytes and CD4 Depleted PBMC's
$10,000 12/1/04 — 12/1/05
Anderson Society of Infectious Diseases Pharmacists (SIDP)
Antiretroviral Pharmacology and Drug Transporter Genetics
$15,000 11/1/04 — 10/31/05
Anderson NIH Sex-and disease-dependent nucleoside analog toxicity
$1,753,820 3/15/05 — 2/28/10
Anderson Glaxo Smith Kline
A Survey for Evidence Of PNP Inhibition In Subjects From ESS3009
$67,421 5/1/05 — 4/30/06
Aquilante American Association of Colleges of Pharmacy
The Effect of Rosiglitazone on Resistin Levels in Nondiabetic Patients with the
Metabolic Syndrome
$10,000 12/1/04 — 12/1/05
Aquilante American College of Clinical Pharmacy
Modulation of Adiponectin in the Metabolic Syndrome
$15,000 7/1/04 — 6/30/05
Carpenter Aventis 
Development of Stable Lyophilized Formulations of Live Attenuated Virus Vaccines
$78,120 7/1/04 — 6/30/05
Carpenter MedImmune Antibody Precipitation during Concentration
with Tangential Flow Filtration: Salting Out or Non-native Aggregation
$80,010 2/1/05 — 1/31/06
Carpenter Abbott Aggregation and Particle Formulation in Therapeutic
Antibody Solutions:  Effects of Solution Conditions and Heterogeneous Nuclei
$89,460 3/1/05 — 2/28/06
Catalano/Maluf NIH 
NIGMS Mechanism of Lambda Terminase DNA Processing
$90,272 7/1/04 — 6/30/06
Fish Bristol Myers Squibb
Pharmacokinetics and Pharmacodynamics of Gatfloxacin in Severly III Adult
Intensive Care Unit Patients
$41,900 6/1/04 — 5/31/06
Fletcher NIH NIAID CFAR
The Role of Sex and HCV Co-invection in HIV Therapy
$944,112 9/30/04 — 3/31/07
Fletcher Social Scientific Systems (NIH sub)
Adult Aids Clinical Trials Group Pharmacology Core Lab
$551,250 4/1/04 — 12/31/05
Franklin NIH NCI
Antiapoptotic Properties of Map Kinase Phosphatase 1
$31,920 5/7/04 — 5/31/04
Gustafson NIH/NCI
Dual Compartmental Targeting of Cancer
$965,536 1/1/05 — 12/31/08
Hoody Astra Zeneca Evaluation of Pharmacokinetic Interactions
Between Crestor and Combination Protease Inhibitor Procuct Kaletra
$225,595 4/1/05 — 10/31/06
Hoody Colorado Center for AIDS Research
Pharmacologic evaluation of HIV infected pregnant women on HAART
$50,000 7/1/04 — 6/30/05
Jones PATH Freeze Protection of Vaccines
$113,775 5/10/05 — 4/9/06
Ju NIH NGMS
The immunosuppressive role of hepatic Kupffer cells
$1,404,805 6/6/05 — 3/31/10
Ju NIH NIDDKD
Role of 15d-PGJ2 Hepatic Macrophages
$291,476 9/1/04 — 6/30/06
Malkinson NIH NCI Lung Tumor Promotion by BHT
$1,671,918 5/21/04 — 3/31/09
McCollum Pfizer
IV Catheter Use and IV to Oral Medication Conversion Opportunities
$29,178 11/8/04 — 6/30/05
McCollum American College of Clinical Pharmacy
Diabetes & depression:  resource use and expenditures
$50,000 7/1/05 — 6/30/07
McCollum American College of Clinical Pharmacy
Impact of Depression on Health Status in Diabetes
$14,873 7/1/04 — 6/30/05
Nair Kaiser
The Impact of Prescription Cost-Sharing on Sevelamer Adherence 
and Clinical laboratory
$3,349 3/1/05 — 7/31/05
Patel NIH/NINDS
Superoxide Radicals in Seizure-Induced Neuronal Death
$1,315,779 4/1/05 — 3/31/06
Radcliffe NIH NIAAA
Zebrafish model: Molecular Basis of Acute EtOH tolerance
$153,916 4/1/04 — 3/31/06
Scheinman Arthritis Foundation/Rocky Mtn. Chapter
Modulation of TNF Signaling Using an Inducible Transgene
$25,000 1/1/05 — 12/31/05
Stringer University of Colorado Cancer Center
Prolongation of Neutrophil Lifespan by Cigarette Smoke:  Implications in Lung
Cancer Pathogenesis
$29,460 2/1/04 — 1/31/05
Sullivan Schering
Impact of changes in prescription drug benefits for SGA
$88,270 3/1/04 — 2/29/05
Sullivan Bristol-Myers Squibb
Cost-effectiveness of coumadin vs. ximelagatran
$108,400 5/1/04 — 4/30/05
Van Den Berg Cancer League of Colorado, Inc
Characterization of caspase-9 resistance in breast cancer cells
$30,000 7/1/04 — 6/30/05
Van Den Berg University of Colorado Cancer Center
A Systemic JNK2 Knockout, a Mammary Inducible JNK1 Knockout Mouse Model
to Study Normal Mammary Gland Development
$20,000 2/1/04 — 1/31/05
Van Den Berg NIH NCI
The role fo JNK in Mammary Tumor Development
$1,499,538 9/29/04 — 8/31/09
Vasiliou NIH NEI
Molecular Mechanisms & Role of Corneal Aldehyde Dehydrogenase
$1,631,997 4/1/04 — 3/31/09
Vondracek Proctor and Gamble
Evaluation of the Relationship between Tumor Necrosis Factor-alpha and Bone
Mineral Density in Men with Severe Chronic Obstructive Pulmonary Disease
$15,000 7/1/04 — 6/30/06
Grants list
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